BrainStorm Cell Therapeutics
BrainStorm Cell Therapeutics Inc. is a clinical-stage biotechnology company based in New York City, specializing in the development of innovative autologous cellular therapies aimed at treating highly debilitating neurodegenerative diseases. Their flagship technology platform, NurOwn, focuses on producing MSC-NTF cells to address significant unmet medical needs in this field.
Committed to advancing treatment options for conditions like ALS, BrainStorm is at the forefront of scientific innovation, working on therapies that are currently investigational and not yet FDA approved. The company’s mission is to defeat neurodegenerative diseases through its best-in-class therapeutic technology.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.